Synthesis of (3-amino-7-chloro-8-methyl-1,1-dioxo-4H-1,5,2-benzo[f] dithiazepin-4-ylidene)acetic acid derivatives as potential antitumor agents

Polish Journal of Chemistry

Volumn 81, Issue 12, 2007, Pages 2133-2142

  Brzozowski, Z ^a   Saczewski F ^a   Slawinski J ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

1,1 dioxo 4H,5,2 benzo f dithiazepines; Antitumor activity; Sulfonamides

Indexed keywords

EID: 39149112502     PISSN: 01375083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Casini A., Scozzafava A., Mastrolorenzo A. and Supuran C.T., Curr. Cancer Drug Targets, 2, 55 (2002).
2. Scozzafava A., Casini A. and Supuran C.T., Curr. Med. Chem., 9, 1167 (2002).
3. Supuran C.T., Casini A. and Scozzafava A., Med. Res. Rev., 23, 535 (2003).
4. Scozzafava A., Owa T., Mastrolorenzo A. and Supuran C.T., Curr. Med. Chem., 10, 925 (2003).
5. Brzozowski Z., Acta Polon. Pharm. Drug Res., 52, 91 (1995).
6. Brzozowski Z., Acta Polon. Pharm. Drug Res., 52, 287 (1995).
7. Brzozowski Z., Acta Polon. Pharm. Drug Res., 53, 269 (1996).
8. Brzozowski Z., Acta Polon. Pharm. Drug Res., 55, 375 (1998).
9. Brzozowski Z. and Kornicka A., Acta Polon. Pharm. Drug Res., 56, 135 (1999).
10. Brzozowski Z., Sa̧czewski F. and Gdaniec M., Eur. J. Med. Chem., 37, 285 (2002).
11. Sławiński J. and Gdaniec M., Eur. J. Med. Chem., 40, 377 (2005).
12. Sławiński J. and Brzozowski Z., Eur. J. Med. Chem., 41, 1180 (2006).
13. Neamati N., Mazumder A., Sunder S., Owen J.H., Schultz R.J. and Pommier Y., Antiviral Chem. Chemother., 8, 485 (1997).
14. Brzozowski Z., Acta Polon. Pharm. Drug Res., 55, 473 (1998).
15. Kuo Ch.L., Assefa H., Brzozowski Z., Sławiński J., Sa̧czewski F., Buolamwini J.K. and Neamati N., J. Med. Chem., 47, 385 (2004).
16. Brzozowski Z., Sa̧czewski F. and Gdaniec M., Bioorg. Med. Chem., 11, 3673 (2003).
17. Brzozowski Z., Sa̧czewski F. and Gdaniec M., Eur. J. Med. Chem., 38, 991 (2003).
18. Brzozowski Z., Acta Polon. Pharm. Drug Res., 54, 293 (1997).
19. Brzozowski Z. and Sa̧czewski F., J. Med. Chem., 45, 430 (2002).
20. Brzozowski Z., Sa̧czewski F. and Neamati N., Bioorg. Med. Chem., 14, 2985 (2006).
21. Pomarnacka E., Kornicka A. and Sa̧czewski F., Heterocycles, 55, 753 (2001).
22. Brzozowski Z., Sa̧czewski F., Sanchez T., Kuo Ch.L., Gdaniec M. and Neamati N., Bioorg. Med. Chem., 12, 3663 (2004).
23. Brzozowski Z., Sa̧czewski F. and Neamati N., Bioorg. Med. Chem. Lett., 16, 5298 (2006).
24. Brzozowski Z. and Sławiński J., Acta Polon. Pharm., 41, 133 (1984).
25. Krubsack A.J. and Higa T., Tetrahedron Lett., 49, 5149 (1968).
26. Cushman M. and Cheng L., J. Org. Chem., 43, 3781 (1978).
27. The geometry of 4 was fully optimized using a semiempirical AM1 method. The calculations were carried out using the Spartan Pro program version 1,0,5 (2000), distributed by Wavefunction Inc.
28. Boyd M.R., Am. Assoc. Cancer Res., 30, 652 (1989).
29. Monks A.P., Scudiero D.A., Skehan P., Shoemaker R., Poull K.D., Vistica D., Hose C., Langley J., Cronise P., Vaigro-Wolff A., Gray-Goodrich M., Cambell H., Mayo J. and Boyd M.J., J. Natl. Cancer Inst., 83, 757 (1991).
30. Weinstein J.N., Myers T.G., O'Connor P.M., Friend S.H., Fornance A.J.Jr., Kohn K.W., Fojo T., Bates S.E., Rubinstein L.V., Anderson N.L., Buolamwini J.K., van Osdol W.W., Monks A.P., Scudiero D.A., Sausiville E.A., Zaharevitz D.W., Bunow B., Viswanadhan V.N., Johnson G.S., Wittes R.E. and Paull K.D., Science, 275, 343 (1997).